IRhythm Technologies Research and Development Expenses 2015-2025 | IRTC
IRhythm Technologies research and development expenses from 2015 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
| IRhythm Technologies Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $104 |
| 2023 | $60 |
| 2022 | $47 |
| 2021 | $39 |
| 2020 | $41 |
| 2019 | $37 |
| 2018 | $21 |
| 2017 | $13 |
| 2016 | $7 |
| 2015 | $6 |
| 2014 | $6 |
| IRhythm Technologies Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $22 |
| 2024-12-31 | $19 |
| 2024-09-30 | $48 |
| 2024-06-30 | $20 |
| 2024-03-31 | $17 |
| 2023-12-31 | $15 |
| 2023-09-30 | $16 |
| 2023-06-30 | $14 |
| 2023-03-31 | $15 |
| 2022-12-31 | $13 |
| 2022-09-30 | $11 |
| 2022-06-30 | $12 |
| 2022-03-31 | $11 |
| 2021-12-31 | $12 |
| 2021-09-30 | $9 |
| 2021-06-30 | $10 |
| 2021-03-31 | $9 |
| 2020-12-31 | $12 |
| 2020-09-30 | $9 |
| 2020-06-30 | $13 |
| 2020-03-31 | $8 |
| 2019-12-31 | $9 |
| 2019-09-30 | $13 |
| 2019-06-30 | $8 |
| 2019-03-31 | $7 |
| 2018-12-31 | $7 |
| 2018-09-30 | $5 |
| 2018-06-30 | $5 |
| 2018-03-31 | $4 |
| 2017-12-31 | $4 |
| 2017-09-30 | $4 |
| 2017-06-30 | $3 |
| 2017-03-31 | $3 |
| 2016-12-31 | $2 |
| 2016-09-30 | $2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $2 |
| 2015-12-31 | |
| 2015-09-30 | $2 |
| 2015-06-30 | $0 |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.915B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.059B | 59.87 |
| Doximity (DOCS) | United States | $11.521B | 53.34 |
| Hims & Hers Health (HIMS) | United States | $11.158B | 115.93 |
| Tempus AI (TEM) | United States | $11.000B | 0.00 |
| Hinge Health (HNGE) | United States | $4.037B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.827B | 59.80 |
| Privia Health (PRVA) | United States | $2.804B | 191.67 |
| Enovis (ENOV) | United States | $1.791B | 9.99 |
| Phreesia (PHR) | United States | $1.693B | 0.00 |
| Schrodinger (SDGR) | United States | $1.476B | 0.00 |
| 10x Genomics (TXG) | United States | $1.426B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.420B | 0.00 |
| Azenta (AZTA) | United States | $1.409B | 65.49 |
| Omnicell (OMCL) | United States | $1.377B | 24.30 |
| Evolent Health (EVH) | United States | $1.322B | 112.60 |
| Claritev (CTEV) | United States | $0.742B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.605B | 0.00 |
| Veradigm (MDRX) | United States | $0.509B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.465B | 139.00 |
| Standard BioTools (LAB) | United States | $0.456B | 0.00 |
| TruBridge (TBRG) | United States | $0.352B | 780.67 |
| Outset Medical (OM) | United States | $0.340B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.262B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.105B | 0.00 |
| Pulmonx (LUNG) | United States | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.086B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.049B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |